close :

:

Forgotten your password?
 
Drug Information
Side Effects > Gemfibrozil

Gemfibrozil Side Effects

Brand Names: Lopid

Please note - some side effects for Gemfibrozil may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).


For the consumer

For the professional

Side Effects of Gemfibrozil - for the consumer


Gemfibrozil

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Gemfibrozil:

Blurred vision; diarrhea; dizziness; gas; headache; indigestion; nausea; stomach pain; tiredness; vomiting.

Seek medical attention right away if any of these SEVERE side effects occur when using Gemfibrozil:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); diarrhea; muscle pain; nausea; persistent or severe stomach pain; tenderness; vomiting; weakness.

Top

For the professional


Gemfibrozil

In the double-blind controlled phase of the primary prevention component of the Helsinki Heart Study, 2046 patients received Gemfibrozil for up to five years. In that study, the following adverse reactions were statistically more frequent in subjects in the Gemfibrozil group:

Gemfibrozil PLACEBO
(N = 2046) (N = 2035)
Frequency in percent of subjects
Gastrointestinal reactions 34.2 23.8
   Dyspepsia 19.6 11.9
   Abdominal pain 9.8 5.6
   Acute appendicitis 1.2 0.6
   (histologically confirmed in most
   cases where data were available)
Atrial fibrillation 0.7 0.1
Adverse events reported by more than 1% of subjects, but without a significant difference between groups:
Diarrhea 7.2 6.5
Fatigue 3.8 3.5
Nausea/Vomiting 2.5 2.1
Eczema 1.9 1.2
Rash 1.7 1.3
Vertigo 1.5 1.3
Constipation 1.4 1.3
Headache 1.2 1.1

Gallbladder surgery was performed in 0.9% of Gemfibrozil and 0.5% of placebo subjects in the primary prevention component, a 64% excess, which is not statistically different from the excess of gallbladder surgery observed in the clofibrate compared to the placebo group of the WHO study. Gallbladder surgery was also performed more frequently in the Gemfibrozil group compared to placebo (1.9% vs 0.3%, p=0.07) in the secondary prevention component. A statistically significant increase in appendectomy in the Gemfibrozil group was seen also in the secondary prevention component (6 on Gemfibrozil vs 0 on placebo, p=0.014).

Nervous system and special senses adverse reactions were more common in the Gemfibrozil group. These included hypesthesia, paresthesias, and taste perversion. Other adverse reactions that were more common among Gemfibrozil treatment group subjects but where a causal relationship was not established include cataracts, peripheral vascular disease, and intracerebral hemorrhage.

From other studies it seems probable that Gemfibrozil is causally related to the occurrence of MUSCULOSKELETAL SYMPTOMS, and to ABNORMAL LIVER FUNCTION TESTS and HEMATOLOGIC CHANGES.

Reports of viral and bacterial infections (common cold, cough, urinary tract infections) were more common in Gemfibrozil treated patients in other controlled clinical trials of 805 patients. Additional adverse reactions that have been reported for Gemfibrozil are listed below by system. These are categorized according to whether a causal relationship to treatment with Gemfibrozil is probable or not established:

CAUSAL RELATIONSHIP CAUSAL RELATIONSHIP
PROBABLE NOT ESTABLISHED
General: weight loss
Cardiac: extrasystoles
Gastrointestinal: cholestatic jaundice pancreatitis
hepatoma
colitis
Central Nervous System: dizziness confusion
somnolence convulsions
paresthesia syncope
peripheral neuritis
decreased libido
depression
headache
Eye: blurred vision retinal edema
Genitourinary: impotence decreased male fertility
renal dysfunction
Musculoskeletal: myopathy
myasthenia
myalgia
painful extremities
arthralgia
synovitis
rhabdomyolysis
Clinical Laboratory: increased creatine positive antinuclear
phosphokinase antibody
increased bilirubin
increased liver
transaminases (AST [SGOT], ALT [SGPT])
increased alkaline
phosphatase
Hematopoietic: anemia thrombocytopenia
leukopenia
bone marrow hypoplasia
eosinophilia
Immunologic: angioedema anaphylaxis
laryngeal edema Lupus-like syndrome
urticaria vasculitis
Integumentary: exfoliative dermatitis alopecia
rash photosensitivity
dermatitis
pruritus

Additional adverse reactions that have been reported include cholecystitis and cholelithiasis (ref. 12).

Top

More resources:

Cerner Multum gemfibrozil

PDR Gemfibrozil

MedFacts Gemfibrozil

Micromedex Gemfibrozil - Includes detailed dosage instructions.

FDA Lopid

Facts & Comparisons Gemfibrozil

FDA Gemfibrozil

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.


Join Drugs.com
Click here to see what benefits you can get by joining our FREE membership programme.
Drugs.com is the most popular, comprehensive, and up-to-date source of drug information online. Providing advice on more than 24,000 prescription drugs and over-the-counter medicines for consumers and professionals .
Advertisement
In The Pipeline